- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b94dbf53-b421-4ca8-8dd6-63314ca2f20c - Date
7/2/2014 - Company Name
Aciex Therapeutics - Mailing Address
470 Atlantic Avenue 4th Floor Boston, MA 02210 USA - Company Description
The company is developing ophthalmic pharmaceutical products to treat ocular diseases. - Website
http://www.aciexrx.com - Transaction Type
M&A - Transaction Amount
$120,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
The transaction, subject to the approval of Nicox’s shareholders, includes a $65 million upfront payment in newly issued Nicox shares, plus contingent value rights giving right to shares, for a potential additional value of up to $55 million.